company background image
VIT logo

Vitura Health ASX:VIT Stock Report

Last Price

AU$0.11

Market Cap

AU$63.3m

7D

-33.3%

1Y

-63.3%

Updated

23 Apr, 2024

Data

Company Financials

VIT Stock Overview

Vitura Health Limited engages in the sale and distribution of medicinal cannabis products in Australia and Asia.

VIT fundamental analysis
Snowflake Score
Valuation4/6
Future Growth0/6
Past Performance3/6
Financial Health6/6
Dividends4/6

Vitura Health Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Vitura Health
Historical stock prices
Current Share PriceAU$0.11
52 Week HighAU$0.60
52 Week LowAU$0.092
Beta0.16
1 Month Change-31.25%
3 Month Change-55.10%
1 Year Change-63.33%
3 Year Change0%
5 Year Changen/a
Change since IPO-67.65%

Recent News & Updates

Does Vitura Health (ASX:VIT) Have A Healthy Balance Sheet?

Apr 11
Does Vitura Health (ASX:VIT) Have A Healthy Balance Sheet?

Investors Don't See Light At End Of Vitura Health Limited's (ASX:VIT) Tunnel And Push Stock Down 37%

Feb 27
Investors Don't See Light At End Of Vitura Health Limited's (ASX:VIT) Tunnel And Push Stock Down 37%

Here's Why We Think Vitura Health (ASX:VIT) Is Well Worth Watching

Feb 25
Here's Why We Think Vitura Health (ASX:VIT) Is Well Worth Watching

Recent updates

Does Vitura Health (ASX:VIT) Have A Healthy Balance Sheet?

Apr 11
Does Vitura Health (ASX:VIT) Have A Healthy Balance Sheet?

Investors Don't See Light At End Of Vitura Health Limited's (ASX:VIT) Tunnel And Push Stock Down 37%

Feb 27
Investors Don't See Light At End Of Vitura Health Limited's (ASX:VIT) Tunnel And Push Stock Down 37%

Here's Why We Think Vitura Health (ASX:VIT) Is Well Worth Watching

Feb 25
Here's Why We Think Vitura Health (ASX:VIT) Is Well Worth Watching

Calculating The Fair Value Of Vitura Health Limited (ASX:VIT)

Dec 13
Calculating The Fair Value Of Vitura Health Limited (ASX:VIT)

Here's Why Shareholders Will Not Be Complaining About Vitura Health Limited's (ASX:VIT) CEO Pay Packet

Nov 21
Here's Why Shareholders Will Not Be Complaining About Vitura Health Limited's (ASX:VIT) CEO Pay Packet

Is Now The Time To Put Vitura Health (ASX:VIT) On Your Watchlist?

Nov 01
Is Now The Time To Put Vitura Health (ASX:VIT) On Your Watchlist?

Here's Why We Think Vitura Health (ASX:VIT) Is Well Worth Watching

Jul 18
Here's Why We Think Vitura Health (ASX:VIT) Is Well Worth Watching

Earnings Not Telling The Story For Cronos Australia Limited (ASX:CAU) After Shares Rise 111%

Sep 12
Earnings Not Telling The Story For Cronos Australia Limited (ASX:CAU) After Shares Rise 111%

If EPS Growth Is Important To You, Cronos Australia (ASX:CAU) Presents An Opportunity

Sep 05
If EPS Growth Is Important To You, Cronos Australia (ASX:CAU) Presents An Opportunity

Shareholder Returns

VITAU PharmaceuticalsAU Market
7D-33.3%-4.8%-3.0%
1Y-63.3%30.9%3.9%

Return vs Industry: VIT underperformed the Australian Pharmaceuticals industry which returned 30.9% over the past year.

Return vs Market: VIT underperformed the Australian Market which returned 3.9% over the past year.

Price Volatility

Is VIT's price volatile compared to industry and market?
VIT volatility
VIT Average Weekly Movement17.7%
Pharmaceuticals Industry Average Movement10.9%
Market Average Movement8.9%
10% most volatile stocks in AU Market17.2%
10% least volatile stocks in AU Market3.4%

Stable Share Price: VIT's share price has been volatile over the past 3 months.

Volatility Over Time: VIT's weekly volatility (18%) has been stable over the past year, but is still higher than 75% of Australian stocks.

About the Company

FoundedEmployeesCEOWebsite
2018n/aRodney Cocksvitura.com.au

Vitura Health Limited engages in the sale and distribution of medicinal cannabis products in Australia and Asia. The company operates CanView, an online platform that delivers prescribing, dispensing, and medication management solutions for medicinal cannabis; CDA Clinics, which provides medicinal cannabis consultations and prescription services; and Cannadoc, a medicinal cannabis clinic that offers telehealth consultations. It also offers psychedelics under the Cortexa brand; and plant-based medications, such as medium chain triglyceride oil and whole flower products under the Adaya brand name.

Vitura Health Limited Fundamentals Summary

How do Vitura Health's earnings and revenue compare to its market cap?
VIT fundamental statistics
Market capAU$63.35m
Earnings (TTM)AU$9.40m
Revenue (TTM)AU$119.66m

6.7x

P/E Ratio

0.5x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
VIT income statement (TTM)
RevenueAU$119.66m
Cost of RevenueAU$81.81m
Gross ProfitAU$37.85m
Other ExpensesAU$28.45m
EarningsAU$9.40m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)0.016
Gross Margin31.63%
Net Profit Margin7.86%
Debt/Equity Ratio15.9%

How did VIT perform over the long term?

See historical performance and comparison

Dividends

9.1%

Current Dividend Yield

60%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.